HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Willy E Peetermans Selected Research

Chronic Renal Insufficiency

1/2022Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Willy E Peetermans Research Topics

Disease

15Infections
05/2022 - 02/2004
9Pneumococcal Infections
02/2023 - 08/2006
6Sepsis (Septicemia)
01/2012 - 11/2002
5Fever (Fevers)
08/2017 - 06/2004
5Endocarditis
11/2016 - 05/2008
4Pneumonia (Pneumonitis)
09/2015 - 12/2011
3Urinary Tract Infections (Urinary Tract Infection)
10/2022 - 06/2011
3Hypersensitivity (Allergy)
10/2022 - 04/2016
3Hemorrhage
04/2022 - 09/2007
3Drug-Related Side Effects and Adverse Reactions
04/2022 - 01/2021
2Critical Illness (Critically Ill)
10/2022 - 01/2012
2Neoplasms (Cancer)
01/2022 - 05/2014
2Inflammation (Inflammations)
10/2019 - 07/2009
2Respiratory Tract Infections (Respiratory Tract Infection)
06/2011 - 02/2008
2Catheter-Related Infections
06/2004 - 11/2002
1Opioid-Induced Constipation
04/2022
1Torsades de Pointes (Torsade de Pointes)
04/2022
1Bacterial Infections (Bacterial Infection)
01/2022
1Breakthrough Infections
01/2022
1Chronic Renal Insufficiency
01/2022
1Febrile Neutropenia
01/2022
1Aspergillosis
09/2021
1Stroke (Strokes)
01/2021
1Heart Failure
01/2021
1Diabetes Mellitus
01/2021
1Persistent Infection
01/2021
1Pain (Aches)
01/2021
1Pyelonephritis
12/2020
1Flushing
11/2020
1Gastroenteritis
01/2019
1Typhoid Fever (Typhoid)
09/2017
1Acquired Immunodeficiency Syndrome (AIDS)
08/2017
1Abdominal Pain (Pain, Abdominal)
04/2016
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
04/2016
1Alcoholism (Alcohol Abuse)
11/2013
1Staphylococcal Infections
07/2013
1Hematologic Neoplasms (Hematological Malignancy)
01/2012
1Necrosis
01/2012
1Endophthalmitis (Ophthalmia)
10/2009
1Embolism (Embolus)
12/2008
1Septic Shock (Toxic Shock Syndrome)
04/2008
1Abscess
11/2007
1Bacteremia
10/2007
1Cryoglobulinemia
03/2007

Drug/Important Bio-Agent (IBA)

10Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2004
4Conjugate VaccinesIBA
02/2023 - 03/2013
3VaccinesIBA
08/2021 - 06/2015
3C-Reactive ProteinIBA
09/2017 - 06/2004
2temocillinIBA
10/2022 - 06/2020
2beta-LactamsIBA
10/2022 - 01/2007
2Cefepime (Maxipime)FDA LinkGeneric
01/2022 - 11/2020
210-valent pneumococcal conjugate vaccineIBA
01/2022 - 01/2021
2Voriconazole (Vfend)FDA LinkGeneric
09/2021 - 10/2009
2Ciprofloxacin (Cipro)FDA LinkGeneric
09/2017 - 01/2012
2FluoroquinolonesIBA
06/2011 - 01/2007
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
02/2023
1VancomycinFDA LinkGeneric
05/2022
1KetorolacIBA
04/2022
1AnticoagulantsIBA
01/2022
1Analgesics (Analgesic Drugs)IBA
01/2021
1AminoglycosidesIBA
12/2020
1Immunoglobulin E (IgE)IBA
01/2019
1fibrin fragment D (D-dimer)IBA
01/2018
116S Ribosomal RNAIBA
11/2016
1Histamine Receptors (Histamine Receptor)IBA
04/2016
1von Willebrand FactorIBA
04/2016
1CoagulaseIBA
04/2016
1ebastine (Kestin)IBA
04/2016
1Histamine (Histamine Dihydrochloride)FDA Link
04/2016
1Polysaccharides (Glycans)IBA
06/2015
1Glucose (Dextrose)FDA LinkGeneric
05/2014
1FibrinIBA
07/2013
1staphylothrombinIBA
07/2013
1DabigatranFDA Link
07/2013
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2012
1Calcineurin InhibitorsIBA
01/2012
1Azithromycin (Zithromax)FDA LinkGeneric
01/2012
1Caspofungin (Cancidas)FDA Link
10/2009
1Ferritins (Ferritin)IBA
07/2009
1Trace Elements (Biometals)IBA
07/2009
14-cresol (p-cresol)IBA
07/2009
1Uremic ToxinsIBA
07/2009
1IronIBA
07/2009
1cefuroxime axetil (Ceftin)FDA LinkGeneric
02/2008
1Cefuroxime (Zinacef)FDA LinkGeneric
02/2008
1P-2 (P 2)IBA
11/2007
1Rituximab (Mabthera)FDA Link
03/2007

Therapy/Procedure

16Therapeutics
05/2022 - 02/2004
8Catheters
10/2019 - 11/2002
3Inappropriate Prescribing
04/2022 - 01/2021
2Phage Therapy
01/2022 - 01/2021
2Renal Dialysis (Hemodialysis)
01/2021 - 07/2009
2Central Venous Catheters
11/2020 - 06/2004
2Length of Stay
03/2013 - 01/2012
1Oral Hygiene (Dental Hygiene)
11/2013
1Transplantation
01/2012
1Resuscitation Orders (Do Not Resuscitate Orders)
01/2012
1Conservative Treatment
04/2008
1Prostheses and Implants (Prosthesis)
10/2007
1Plasmapheresis
03/2007